Japanese Single-Center Experience of Surgery for Chronic Thromboembolic Pulmonary Hypertension
Hitoshi Ogino(Tokyo Medical University Hospital), Soichiro Kitamura(National Cerebral and Cardiovascular Center), Hitoshi Matsuda(National Cerebral and Cardiovascular Center), Hiroaki Sasaki(National Cerebral and Cardiovascular Center), Kenji Minatoya(National Cerebral and Cardiovascular Center), Shingo Kyotani(National Cerebral and Cardiovascular Center), Hideaki Imanaka(National Cerebral and Cardiovascular Center), Motomi Ando(Fujita Health University Hospital), Norifumi Nakanishi(National Cerebral and Cardiovascular Center)
Cited by 138
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
|Human Mutation|2006|404
Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|Circulation Cardiovascular Interventions|2012|381
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
|Circulation Cardiovascular Quality and Outcomes|2017|336